Velon^®-M

Therapeutic Segment:
Anti-diabetic

Generic Name:
Vildagliptin+Metformin HCI

Description:
Velon®-M combines two oral hypoglycaemic agents with complimentary mechanisms of action to improve glycaemic control in patients with type 2 diabetes. Vildagliptin, a member of the islet enhancer class and Metformin, a member of the biguanide class.

Indication:
Velon®-M is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes whose diabetes is not adequately controlled on metformin hydrochloride alone or who are already treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. Treatment of type 2 diabetes should not be initiated with this fixed-dose combination.

Formulation:

• Tablets

Strength:

• 50/850mg
• 50/1000mg
• 50/500mg

Pack Size:

• 14’s
• 28’s